| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Larimar Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 19K | May 13, 2025 | Direct | ||
| BiomX Inc. | Director | Common Stock Options - right to Buy | 17.6K | Apr 14, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LRMR | Larimar Therapeutics, Inc. | May 13, 2025 | 1 | $0 | 4 | May 14, 2025 | Director |
| PHGE | BiomX Inc. | Apr 14, 2025 | 1 | $0 | 4/A | Apr 21, 2025 | Director |
| PHGE | BiomX Inc. | Jul 11, 2024 | 1 | $0 | 4 | Jul 15, 2024 | Director |
| LRMR | Larimar Therapeutics, Inc. | May 29, 2024 | 1 | $0 | 4 | May 31, 2024 | Director |
| PHGE | BiomX Inc. | Mar 15, 2024 | 0 | $0 | 3 | Mar 21, 2024 | Director |
| LRMR | Larimar Therapeutics, Inc. | May 9, 2023 | 1 | $0 | 4 | May 11, 2023 | Director |
| SPRY | ARS Pharmaceuticals, Inc. | Nov 8, 2022 | 0 | $0 | 3 | Nov 10, 2022 | Director |
| LRMR | Larimar Therapeutics, Inc. | May 10, 2022 | 1 | $0 | 4 | May 12, 2022 | Director |
| LRMR | Larimar Therapeutics, Inc. | May 12, 2021 | 1 | $0 | 4 | May 17, 2021 | Director |